HongK.D., BaeJ.H., JangY.J., JungH.Y., ChoJ.H., ChoiJ.Y.Encapsulating peritoneal sclerosis: case series from a university center.Korean J Intern Med2013; 28: 587–93.
2.
VidalE., EdefontiA., PuteoF., ChimenzR., GianoglioB., LavorattiG.Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis.Nephrol Dial Transplant2013; 28: 1603–9.
3.
HabibS.M., KorteM.R., BetjesM.G.Lower mortality and inflammation from post-transplantation encapsulating peritoneal sclerosis compared to the classical form.Am J Nephrol2013; 37: 223–30.
4.
ShroffR., StefanidisC.J., AskitiV., EdefontiA., TestaS., EkimM.Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.Nephrol Dial Transplant2013; 28: 1908–14.
5.
LatusJ., UlmerC., FritzP., RettenmaierB., BieggerD., LangT.Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany.Nephrol Dial Transplant2013; 28: 1021–30.
6.
LoW.K., KawanishiH.Encapsulating peritoneal sclerosis – medical and surgical treatment.Perit Dial Int2009; 29: S211–4.
7.
OhsawaI., IshikawaM., TakahashiK., WatanabeM., NishimakiK., YamagataK.Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.Nat Med2007; 13: 688–94.
8.
OhtaS.Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications.Curr Pharm Des2011; 17: 2241–52.
9.
HuangK.C., YangC.C., LeeK.T., ChienC.T.Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water.Kidney Int2003; 64: 704–14.
10.
HuangK.C., HsuS.P., YangC.C., Ou-YangP., LeeK.T., MorisawaS.Electrolysed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients.Kidney Int2006; 70: 391–8.
11.
HuangK.C., HsuS.P., YangC.C., Ou-YangP., LeeK.T., MorisawaS.Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.Nephrol Dial Transplant2010; 25: 2730–7.
12.
NakayamaM., KabayamaS., TerawakiH., NakayamaK., KatoK., SatoT.Less-oxidative hemodialysis solution rendered by cathode-side application of electrolyzed water.Hemodial Int2007; 11: 322–7.
13.
NakayamaM., KabayamaS., NakanoH., ZhuW.J., TerawakiH., NakayamaK.Biological effects of electrolyzed water in hemodialysis.Nephron Clin Pract2009; 112: c9–15.
14.
NakayamaM., NakanoH., HamadaH., ItamiN., NakazawaR., ItoS.A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial.Nephrol Dial Transplant2010; 25: 3026–33.
15.
TerawakiH., ZhuW.J., MatsuyamaY., TeradaT., TakahashiY., SakuraiK.Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients.Hemodial Int2014; 18: 459–66.
16.
TerawakiH., HayashiY., ZhuW.J., MatsuyamaY., TeradaT., KabayamaS.Transperitoneal administration of dissolved hydrogen for peritoneal dialysis patients. A novel approach to suppress oxidative stress in the peritoneal cavity.Med Gas Res2013; 3: 14.
17.
AllariaP.M., GiangrandeA., GandiniE., PisoniI.B.Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?J Nephrol1999; 12: 395–7.
18.
EvrenkayaT.R., AtasoyuE.M., UnverS., BasekimC., BalogluH., TulbekM.Y.Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant2004; 19: 2423–4.
19.
SummersA.M., ClancyM.J., SyedF., HarwoodN., BrenchleyP.E., AugustineT.Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.Kidney Int2005; 68: 2381–8.
20.
BhandariS., WilkinsosA., SellarsL.Sclerosing peritonitis: value of immunosuppression prior to surgery.Nephrol Dial Transplant1994; 9: 436–7.
21.
del PesoG., BajoM.A., GilF., AguileraA., RosS., CosteroO.Clinical experience with tamoxifen in peritoneal fibrosing syndromes.Adv Perit Dial2003; 19: 32–5.
22.
KawanishiH., KawaguchiY., FukuiH., HaraS., ImadaA., KuboH.Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.Am J Kidney Dis2004; 44: 729–37.
23.
FontanariP., BadierM., GuillotC., TomeiC., BurnetH., GardetteB.Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive.Eur J Appl Physiol2000; 81: 325–8.
24.
OhtaS.Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications.Curr Pharm Des2011; 17: 2241–52.
25.
OhsawaI., NishimakiK., YamagataK., IshikawaM., OhtaS.Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice.Biochem Biophys Res Commun2008; 377: 1195–8.
26.
SatoY., KajiyamaS., AmanoA., KondoY., SasakiT., HandaS.Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice.Biochem Biophys Res Commun2008; 375: 346–50.
27.
Nakashima-KamimuraN., MoriT., OhsawaI., AsohS., OhtaS.Molecular hydrogen alleviates nephrotoxicity induced by anti-cancer drug cisplatin without compromising anti-tumor activity in mice.Cancer Chemother Pharmacol2009; 64: 753–61.
28.
CardinalJ.S., ZhanJ., WangY., SugimotoR., TsungA., McCurryK.R.Oral hydrogen water prevents chronic allograft nephropathy in rats.Kidney Int2010; 77: 101–9.
29.
ZhuW.J., NakayamaM., MoriT., NakayamaK., KatohJ., MurataY.Intake of water with high levels of dissolved hydrogen (H2) suppresses ischemia-induced cardio-renal injury in Dahl salt-sensitive rats.Nephrol Dial Transplant2011; 26: 2112–8.
30.
KajiyamaS., HasegawaG., AsanoM., HosodaH., FukuiM., NakamuraN.Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.Nutr Res2008; 28: 137–43.
31.
NakaoA., ToyodaY., SharmaP., EvansM., GuthrieN.Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome – an open label pilot study.J Clin Biochem Nutr2010; 46: 140–9.
32.
ItoM., IbiT., SahashiK., IchiharaM., ItoM., OhnoK.Open-label trial and randomized, double-blind, placebo-controlled crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies.Med Gas Res2011; 1: 24.
33.
IshibashiT., SatoB., RikitakeM., SeoT., KurokawaR., HaraY.Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study.Med Gas Res2012; 2: 27.
